Poseida Therapeutics Inc
(PSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -123,430 | -64,002 | -124,974 | -129,775 | -86,527 |
| Depreciation Amortization | -1,963 | 4,241 | 5,324 | 3,217 | 1,918 |
| Accounts receivable | 77 | -9,088 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,038 | -6,748 | 7,842 | -4,171 | 1,530 |
| Other Working Capital | 14,081 | 13,715 | 20,168 | 5,623 | 9,467 |
| Other Operating Activity | 18,030 | 35,110 | -10,903 | 11,778 | 9,094 |
| Operating Cash Flow | $-92,167 | $-26,772 | $-102,543 | $-113,328 | $-64,518 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,200 | -199,422 | 225,000 | -187,523 | -37,308 |
| PPE Investments | -3,066 | -3,912 | -2,616 | -16,908 | -5,156 |
| Investing Cash Flow | $39,134 | $-203,334 | $222,384 | $-204,431 | $-42,464 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 30,000 | N/A | N/A | 10,000 |
| Common Stock Issued | 16,621 | 76,609 | 2,518 | 210,129 | 4,711 |
| Other Financing Activity | -494 | -1,450 | 0 | 103,812 | 149,660 |
| Financing Cash Flow | $16,127 | $105,159 | $2,518 | $313,941 | $164,371 |
| Beginning Cash Position | 81,378 | 206,325 | 83,966 | 87,784 | 30,395 |
| End Cash Position | 44,472 | 81,378 | 206,325 | 83,966 | 87,784 |
| Net Cash Flow | $-36,906 | $-124,947 | $122,359 | $-3,818 | $57,389 |
| Free Cash Flow | |||||
| Operating Cash Flow | -92,167 | -26,772 | -102,543 | -113,328 | -64,518 |
| Capital Expenditure | -3,066 | -3,924 | -2,634 | -16,908 | -5,156 |
| Free Cash Flow | -95,233 | -30,696 | -105,177 | -130,236 | -69,674 |